UK markets close in 7 hours 30 minutes
  • FTSE 100

    7,119.97
    +10.00 (+0.14%)
     
  • FTSE 250

    22,493.68
    -16.44 (-0.07%)
     
  • AIM

    1,239.83
    +1.35 (+0.11%)
     
  • GBP/EUR

    1.1640
    -0.0024 (-0.20%)
     
  • GBP/USD

    1.3911
    -0.0010 (-0.07%)
     
  • BTC-GBP

    24,641.85
    +903.57 (+3.81%)
     
  • CMC Crypto 200

    821.79
    +35.17 (+4.47%)
     
  • S&P 500

    4,266.49
    +24.65 (+0.58%)
     
  • DOW

    34,196.82
    +322.58 (+0.95%)
     
  • CRUDE OIL

    73.49
    +0.19 (+0.26%)
     
  • GOLD FUTURES

    1,782.10
    +5.40 (+0.30%)
     
  • NIKKEI 225

    29,066.18
    +190.95 (+0.66%)
     
  • HANG SENG

    29,284.50
    +402.04 (+1.39%)
     
  • DAX

    15,576.33
    -12.90 (-0.08%)
     
  • CAC 40

    6,624.21
    -6.94 (-0.10%)
     

Chemed Corporation’s Board of Directors Authorizes an Additional $300 Million for Stock Repurchase

  • Oops!
    Something went wrong.
    Please try again later.
·1-min read
  • Oops!
    Something went wrong.
    Please try again later.

Chemed Corporation (NYSE:CHE) announced today that the Board of Directors has formally authorized an additional $300 million for stock repurchase under Chemed’s existing share repurchase program. These share repurchases will be funded through a combination of cash generated from operations as well as utilization of its revolving credit facility.

Listed on the New York Stock Exchange and headquartered in Cincinnati, Ohio, Chemed Corporation (www.chemed.com) operates two wholly owned subsidiaries: VITAS Healthcare and Roto-Rooter. VITAS is the nation’s largest provider of end-of-life hospice care and Roto-Rooter is the nation’s leading provider of plumbing and drain cleaning services.

Statements in this press release or in other Chemed communications may relate to future events or Chemed’s future performance. Such statements are forward-looking statements and are based on present information Chemed has related to its existing business circumstances. Investors are cautioned that such forward-looking statements are subject to inherent risk that actual results may differ materially from such forward-looking statements. Further, investors are cautioned that Chemed does not assume any obligation to update forward-looking statements based on unanticipated events or changed expectations.

View source version on businesswire.com: https://www.businesswire.com/news/home/20210518005138/en/

Contacts

David P. Williams
(513) 762-6901

Our goal is to create a safe and engaging place for users to connect over interests and passions. In order to improve our community experience, we are temporarily suspending article commenting